I
116th CONGRESS
1st Session
H. R. 3520
IN THE HOUSE OF REPRESENTATIVES
June 26, 2019
Mr. Smith of New Jersey (for himself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Short title
This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2019
.
Reauthorization of the C.W. Bill Young Cell Transplantation Program
In general
Section 379(d)(2)(B) of the Public Health Service Act (42 U.S.C. 274k(d)(2)(B)) is amended—
by striking including remote collection, consistent with the inventory
and inserting including collection, consistent with the inventory
; and
by inserting including remote collection,
before consistent with the requirements
.
Advisory council meetings
Subsection (a) of section 379 of the Public Health Service Act (42 U.S.C. 274k) is amended by adding at the end the following new paragraph:
The Secretary shall convene the Advisory Council at least two times each calendar year.
.
Authorization of appropriations
Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking $33,000,000 for fiscal year 2015 and $30,000,000 for each of fiscal years 2016 through 2020
and inserting $30,000,000 for each of fiscal years 2020 through 2024
.
Cord blood inventory
Subsection (g) of section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended to read as follows:
Authorization of appropriations
To carry out this section, there is authorized to be appropriated $23,000,000 for each of fiscal years 2020 through 2024.
.
